The Clorox Income Statement Annual
CLX
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Annual GAAP In millions $) |
(Jun 30 2015) 2015 |
(FY 2014) (June 30. 2014) |
(FY 2013) (June 30. 2013) |
(FY 2012) (June 30. 2012) |
(FY 2011) (June 30. 2011) |
Revenue From Contract With Customer Excluding Assessed Tax |
- |
5,591.00 |
5,623.00 |
5,468.00 |
5,231.00 |
Total Revenue |
5,655.00 |
5,591.00 |
5,623.00 |
5,468.00 |
5,231.00 |
Cost of Goods and Services Sold |
3,190.00 |
3,231.00 |
3,211.00 |
3,164.00 |
2,958.00 |
Gross
Profit |
2,465.00 |
2,360.00 |
2,412.00 |
2,304.00 |
2,273.00 |
Selling, Administration, Marketing |
798.00 |
1,269.00 |
1,307.00 |
1,280.00 |
1,237.00 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
136.00 |
125.00 |
130.00 |
121.00 |
115.00 |
Asset Impairment Charges |
- |
- |
- |
- |
262.00 |
Other operatinig exp. /-income |
- |
- |
- |
- |
- |
Special Items |
- |
- |
- |
- |
- |
Total operating costs including COS |
4,124.00 |
4,625.00 |
4,648.00 |
4,565.00 |
4,572.00 |
Operating income/-loss
|
1,531.00 |
966.00 |
975.00 |
903.00 |
659.00 |
Other Deductions / - Income |
Interest expense |
100.00 |
103.00 |
122.00 |
125.00 |
123.00 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
100.00 |
103.00 |
122.00 |
125.00 |
123.00 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Income from affiliates |
- |
- |
- |
- |
- |
Sale of Business |
- |
- |
- |
- |
- |
Financing Loss/ -Income |
- |
- |
- |
- |
- |
Other loss/ -income |
510.00 |
2.00 |
- |
-13.00 |
-27.00 |
Total costs & expenses |
4,734.00 |
4,730.00 |
4,770.00 |
4,677.00 |
4,668.00 |
Income /-loss before income taxes |
921.00 |
861.00 |
853.00 |
791.00 |
563.00 |
Income taxes expenses/-benefit |
315.00 |
299.00 |
279.00 |
248.00 |
276.00 |
Income after income taxes |
606.00 |
562.00 |
574.00 |
543.00 |
287.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
606.00 |
562.00 |
574.00 |
543.00 |
287.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
-26.00 |
-4.00 |
-2.00 |
-2.00 |
270.00 |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
580.00 |
558.00 |
572.00 |
541.00 |
557.00 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
580.00 |
558.00 |
572.00 |
541.00 |
557.00 |
EBIT |
0.00 |
964.00 |
975.00 |
916.00 |
686.00 |
EBITD |
0.00 |
1,144.00 |
1,157.00 |
1,094.00 |
859.00 |
EBITDA |
0.00 |
1,144.00 |
1,157.00 |
1,094.00 |
859.00 |
Per
Share (GAAP Annual, in $) |
(Jun 30 2015) 2015 |
(FY 2014) (June 30. 2014) |
(FY 2013) (June 30. 2013) |
(FY 2012) (June 30. 2012) |
(FY 2011) (June 30. 2011) |
Basic EPS (excl. extra
items) |
4.65 |
4.34 |
4.38 |
4.15 |
2.09 |
Extraordinary items |
-0.20 |
-0.03 |
-0.01 |
-0.01 |
1.97 |
Basic Net EPS |
4.45 |
4.31 |
4.37 |
4.14 |
4.06 |
Basic shares outstanding (Mill.
of Units) |
130.31 |
129.56 |
131.08 |
132.57 |
136.70 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
4.37 |
4.26 |
4.31 |
4.09 |
4.02 |
Diluted average shares (Mill.
of Units) |
132.78 |
131.74 |
132.97 |
132.31 |
138.10 |
Dividend per share |
- |
2.79 |
2.52 |
2.38 |
2.19 |
|
|